Announcements Trials
Browse Landscape

Phase

Phase 2 10Phase 1 10Phase 1/2 6Phase 3 5Phase NA 1Phase EARLY_PHASE1 1

Status

Terminated 3Recruiting 1Completed 1

Sponsor Class

INDUSTRY 5

Study Type

Interventional 5

Sponsor

Cancer Type

CNS 4Sarcoma 2

Conditions

Glioblastoma 39Brain Neoplasms 17Astrocytoma 16Central Nervous System Neoplasms 9Oligodendroglioma 8Gliosarcoma 8Melanoma 7Glioma 7Neoplasms 5Recurrence 4Neoplasm Metastasis 3Neuroblastoma 2Ganglioneuroblastoma 2Diffuse Intrinsic Pontine Glioma 2Choroid Plexus Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Sarcoma, Ewing 1Sarcoma 1Rhabdoid Tumor 1Rare Diseases 1Optic Nerve Glioma 1Neurotoxicity Syndromes 1Neuroendocrine Tumors 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms, Neuroepithelial 1Neoplasms, Connective and Soft Tissue 1Neoplasms, Connective Tissue 1Neoplasms, Bone Tissue 1Neoplasms by Histologic Type 1Melanoma, Cutaneous Malignant 1

Interventions

Paclitaxel 20Gemcitabine 16Dexamethasone 16Bevacizumab 16Docetaxel 15Oxaliplatin 14Cyclophosphamide 13Carboplatin 12Capecitabine 12Sorafenib 11Fluorouracil 11Leucovorin 10Cisplatin 10pembrolizumab 9Pemetrexed 9Epoetin Alfa 9venetoclax 8Prednisone 8Fentanyl 8Drug Therapy 8Doxorubicin 8atezolizumab 7Rivaroxaban 7Rituximab 7Darbepoetin alfa 7Anastrozole 7Panitumumab 6Ondansetron 6Morphine 6Irinotecan 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × Neoplasms × Temozolomide × Clear all
NCT07195591 2026-04-30

BRIDGES

GT Medical Technologies, Inc.

Phase 3 Recruiting
766 enrolled
CNS

Glioblastoma, Neoplasms

NCT03495921 2023-04-26

VITA

Gradalis, Inc.

Phase 3 Terminated
32 enrolled 13 charts
Sarcoma

Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective Tissue, Sarcoma, Sarcoma, Ewing, Neoplasms, Connective and Soft Tissue, Neoplasms, Bone Tissue, Neuroectodermal Tumors, Primitive, Peripheral, Rare Diseases

NCT03419403 2021-04-14

UNITE Study: Understanding New Interventions With GBM ThErapy

AbbVie

Phase 3 Terminated
40 enrolled 16 charts
CNS

Glioblastoma, Neoplasms

NCT01480479 2018-01-16

ACT IV

Celldex Therapeutics

Phase 3 Completed
745 enrolled
CNSSarcoma

Brain Neoplasms, Glioblastoma, Neoplasms, Gliosarcoma

NCT00761280 2014-11-14

SAPPHIRE

Isarna Therapeutics GmbH

Phase 3 Terminated
27 enrolled 28 charts
CNS

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡